| 2025-12-18 |
详情>>
内部人交易：
Todisco Joseph共交易2笔
|
| 2025-11-12 |
详情>>
股本变动：
变动后总股本7878.90万股
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益2.12美元,归母净利润1.49亿美元,同比去年增长574.72%
|
| 2025-11-12 |
财报披露：
美东时间 2025-11-12 盘前发布财报
|
| 2025-10-24 |
股东大会：
将于2025-11-10召开股东大会
会议内容 ▼▲
- 1.To approve, for the purposes of Nasdaq Rule 5635(a), the Exchange Cap Removal (as defined herein) (the “Exchange Cap Removal Proposal”);
2.To approve an amendment to the Amended and Restated 2019 Omnibus Stock Incentive Plan to increase the number of shares authorized for issuance thereunder by 4,312,000 shares (the “Incentive Plan Amendment Proposal”);
3.To approve the adoption of resolutions that have been adopted by our Board of Directors to ratify the COD Amendments (as defined herein) (the “Ratification of COD Amendments Proposal”);
4.To approve an amendment to the Company’s amended and restated Certificate of Incorporation to allow the holders of our preferred stock to vote on any amendment to the Company’s Certificate of Incorporation (including any certificates of designations relating to any series of preferred stock (the “Certificate of Designations”)) that relates solely to terms of one or more outstanding series of preferred stock without further approval from the Company’s common stock, subject to applicable law (the “Certificate of Incorporation Amendment Proposal”);
5.To approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the Exchange Cap Removal Proposal, the Incentive Plan Amendment Proposal, the Ratification of COD Amendments Proposal or the Certificate of Incorporation Amendment Proposal (the “Adjournment Proposal”).
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益0.60美元,归母净利润4047.19万美元,同比去年增长241.42%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益0.32美元,归母净利润2064.39万美元,同比去年增长242.71%
|
| 2025-04-28 |
股东大会：
将于2025-06-24召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the 2026 Annual Meeting of Stockholders and until their successor is duly elected and qualified or until their earlier resignation, removal, incapacity or death;
2.To approve on a non-binding advisory basis the compensation of our named executive officers for 2024;
3.To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
4.To act upon such other matters as may properly come before the meeting or any adjournment, postponement or continuation thereof.
|
| 2025-03-25 |
详情>>
业绩披露：
2024年年报每股收益-0.3美元,归母净利润-1793万美元,同比去年增长61.31%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.54美元,归母净利润-3139.44万美元,同比去年增长0.60%
|
| 2024-10-08 |
股东大会：
将于2024-11-21召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve on a non-binding advisory basis the compensation of our named executive officers for 2023;
3.To approve an amendment to the Amended and Restated 2019 Omnibus Stock Incentive Plan to increase the number of shares authorized for issuance thereunder by 3,360,000 shares;
4.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
5.To act upon such other matters as may properly come before the meeting or any adjournment, postponement or continuation thereof.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.5美元,归母净利润-2861.76万美元,同比去年增长-31.03%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.25美元,归母净利润-1446.61万美元,同比去年增长-36.9%
|
| 2024-03-12 |
详情>>
业绩披露：
2023年年报每股收益-0.91美元,归母净利润-4633.92万美元,同比去年增长-56.02%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.65美元,归母净利润-3158.52万美元,同比去年增长-46.96%
|
| 2023-09-13 |
股东大会：
将于2023-10-26召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve on a non-binding advisory basis the compensation of our named executive officers for 2022;
3.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
4.To act upon such other matters as may properly come before the meeting or any adjournment, postponement or continuation thereof.
|
| 2023-08-08 |
详情>>
业绩披露：
2023年中报每股收益-0.49美元,归母净利润-2184.08万美元,同比去年增长-49.2%
|
| 2022-08-30 |
股东大会：
将于2022-10-13召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve on a non-binding advisory basis our executive compensation;
3.To approve the amended and restated 2019 Omnibus Stock Incentive Plan;
4.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
5.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2021-10-29 |
股东大会：
将于2021-12-09召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the 2022 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve on a non-binding advisory basis our executive compensation;
3.To approve on a non-binding advisory basis the frequency of future advisory votes on executive compensation;
4.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
5.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-01 |
复牌提示：
2021-03-01 08:25:08 停牌，复牌日期 2021-03-01 09:00:00
|
| 2020-11-04 |
股东大会：
将于2020-12-16召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the 2021 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2019-10-17 |
股东大会：
将于2019-11-26召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the 2020 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve the CorMedix Inc. 2019 Omnibus Stock Incentive Plan;
3.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
4.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2019-03-26 |
详情>>
拆分方案：
每5.0000合并分成1.0000股
|
| 2018-11-01 |
股东大会：
将于2018-12-11召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the 2019 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve on a non-binding advisory basis our executive compensation;
3.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
4.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2018-05-17 |
股东大会：
将于2018-06-26召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Certificate of Incorporation to effect a reverse stock split at a ratio of between 1-for-5 and 1-for-10, as determined by our Board of Directors, at any time before June 26, 2019, if and as determined by our Board of Directors;
2.To approve an adjournment of the special meeting, if necessary, to solicit, additional proxies if there are not sufficient votes in favor of Proposal No. 1;
3.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2017-04-24 |
股东大会：
将于2017-06-06召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the 2018 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of capital stock from 82,000,000 shares to 202,000,000 shares and to increase the number of authorized shares of common stock from 80,000,000 shares to 200,000,000 shares;
3.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
4.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2016-05-04 |
股东大会：
将于2016-06-13召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve until the 2017 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve amendments to our 2013 Stock Incentive Plan to (i) increase the number of authorized shares of common stock reserved for issuance thereunder from 8,000,000 shares to 11,000,000 shares and (ii) increase the maximum number of shares of common stock underlying stock options and stock appreciation rights that may be granted to any employee from 500,000 to 2,000,000 per year;
3.To ratify the appointment of Friedman LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
4.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2015-11-25 |
股东大会：
将于2016-01-19召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our 2013 Stock Incentive Plan to increase the number of authorized shares of common stock reserved for issuance thereunder from 5,000,000 shares to 8,000,000 shares;
2.To act upon such other matters as may properly come before the meeting or any adjournment thereof.
|